title: Inflammation's role in rectal cancer following prostate radiotherapy, and emerging evidence for a protective role for balsalazide.
authors.forename: Christopher D
authors.initials: CD
authors.lastname: Jahraus
authors.forename: David T
authors.initials: DT
authors.lastname: Rubin
authors.forename: Ellen J
authors.initials: EJ
authors.lastname: Scherl
authors.forename: Doug
authors.initials: D
authors.lastname: Bettenhausen
mesh_terms: D000636:Aminosalicylic Acids / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D008297:Male; D019804:Mesalamine; D009381:Neoplasms, Radiation-Induced / Q000517:prevention & control*; D010659:Phenylhydrazines; D011322:Primary Prevention / Q000379:methods; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000532:radiotherapy*; D011832:Radiation Injuries / Q000517:prevention & control; D012004:Rectal Neoplasms / Q000209:etiology / Q000517:prevention & control*; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D000636:Aminosalicylic Acids; D010659:Phenylhydrazines; D019804:Mesalamine; C038637:balsalazide